Atlas Trials

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

Clinical trial NCT05737771 · UNKNOWN

Trial details

NCT number
NCT05737771
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
FDCDiabetes Mellitus, Type 2
Start date
2023-01-25
Primary completion
2023-03-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.